로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > Gastrin-17

Gastrin-17

요약

Name:Gastrin 17
Target Synonym:Gastrin component II,Gastrin component III,GAS,G52,G34,G14,G17,G6,GAST,Gastrin component I,Gastrin-34,Gastrin-17,Gastrin,Preprogastrin
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

제품 리스트 구매

제품 상태별:
제품 유형별 :
종별:
결합물별:
제품번호 제품 설명 구조 순도 특징
GA7-H82F4 Human Biotinylated Human Gastrin-17 Protein, Fc,Avitag™ (MALS verified)
GA7-H82F4-sds

일부의 생물활성 데이터

GA7-H82F4-MALS-HPLC
Gastrin-17 MALS images

The purity of Biotinylated Human Gastrin-17, Fc,Avitag (Cat. No. GA7-H82F4) is more than 90% and the molecular weight of this protein is around 60-70 kDa verified by SEC-MALS.

GA7-H82F4-ELISA
 Gastrin-17 ELISA

Immobilized Anti-Gastrin-17 antibody, Human IgG1 at 2 μg/mL (100 μL/well) can bind Biotinylated Human Gastrin-17, Fc,Avitag (Cat. No. GA7-H82F4) with a linear range of 0.1-2.5 ng/mL (QC tested).

Synonym Name

gastrin-17,gastrin 17,gastrin

Background

Gastrin is a peptide hormone that stimulates secretion of gastric acid (HCl) by the parietal cells of the stomach and aids in gastric motility. It is released by G cells in the pyloric antrum of the stomach, duodenum, and the pancreas. Gastrin binds to cholecystokinin B receptors to stimulate the release of histamines in enterochromaffin-like cells, and it induces the insertion of K+/H+ ATPase pumps into the apical membrane of parietal cells (which in turn increases H+ release into the stomach cavity). Its release is stimulated by peptides in the lumen of the stomach.

Clinical and Translational Updates

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Polyclonal antibody stimulator (Cancer Advances) G-17DT Phase 2 Clinical Aphton Corp Diabetes Mellitus, Type 1; Stomach Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Jaundice Details
Polyclonal antibody stimulator (Cancer Advances) G-17DT Phase 2 Clinical Aphton Corp Diabetes Mellitus, Type 1; Stomach Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Jaundice Details

This web search service is supported by Google Inc.

totop